On March 8, 2023 Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, reported that Shawn Iadonato, Ph.D., Chief Executive Officer of Kineta, will present a corporate overview at the Oppenheimer 33rd Annual Healthcare Conference, a virtual event to be held on March 13-15, 2023 (Press release, Kineta, MAR 8, 2023, View Source;utm_medium=rss&utm_campaign=kineta-to-present-at-the-oppenheimer-33rd-annual-healthcare-conference [SID1234628309]). The company’s management team will also be available for virtual one-on-one meetings during the conference.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event: Oppenheimer 33rd Annual Healthcare Conference (Virtual)
Format: Virtual Presentation
Date: Monday, March 13, 2023
Time: 9:20-9:50 A.M. Eastern Time
The webcast presentation will be available for viewing and replay under Events & Presentations in the Investor section of the company’s website at www.kinetabio.com.